Tag Archives: UPDATE

New study: Around Half of Top Websites Still Failing User Experience Requirements Introduced in Google’s Core Web Vitals Update

Fashion and travel perform worse on user experience than other verticals according to data from Searchmetrics Berlin / San Mateo, November 29, 2021 – New research from Searchmetrics suggests around 50% of the top 100 most visible[1] websites on Google.com still fail to deliver a “good” page experience on desktop as defined in the search… Read More »

The Digital Transformation of Patients – Update from Rock Health and Stanford

The coronavirus pandemic accelerated digital transformation of organizations, including health care providers. But another patient side-effect of COVID-19 has been the digital transformation of many patients, documented by data gathered by Rock Health and Stanford Center for Digital Health and analyzed in their latest report explaining how the public health crisis accelerated digital health “beyond… Read More »

Telehealth Update from J.D. Power, Amwell, Cigna, GoodRx, and a Trio of Smart Doctors

In the first six months of the COVID-19 pandemic, telehealth was a “bright spot in the ‘new normal,’” according to a report from J.D. Power, Telehealth Patient Satisfaction Surges During Pandemic but Barriers to Access Persist. But as the report’s title asserts, most telehealth users experienced obstacles to accessing and using virtual care platforms that… Read More »

Coronavirus symptoms update: Scientists have identified a common warning sign on skin

Coronavirus has not been kind to incumbent governments – they have had to mobilise vast resources and make era-defining policy decisions. To compound matters, they have had a relatively short time frame to do all this. Even so, there are some merits to the charges levelled against the UK government. The NHS has been criticised… Read More »

FDA Approves Label Update for Crysvita (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH) in Pediatric Patients 6 Months of Age and Older

Print this page NOVATO, Calif., and TOKYO, Sept. 30, 2019 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare diseases, and Kyowa Kirin Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for Crysvita (burosumab). The label has been updated to include… Read More »